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2ABSTRACT
The prevalence study and the characterization of hepatitis C virus (HCV) have
been carried out in the Philippines and the sequence determination of 5’-
untranslated region (5’-UTR)-Core and NS5B regions of HCV was performed in this
study. An HCV strain (SE-03-07-1689) collected in Metro Manila, Philippines,
belonged to discordant subtypes, 2b and 1b in 5’-UTR-Core and NS5B regions,
respectively. The 9.3kb-sequence of this strain including the entire open reading
frame were compared with those of the reference strains retrieved from the HCV
sequences database (GenBank/EMBL/DDBJ) and indicated a recombination event.
The computation of the sequence similarity mapped a crossover point within NS3
region. This is the second report on the inter-genotype recombinant of HCV and
the third one when an intra-genotype recombinant is included. This recombinant
strain, SE-03-07-1689, is tentatively designated as RF3_2b/1b according to the
suggestions used for other two HCV recombinants.
3INTRODUCTION
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a
potential cause of substantial morbidity and mortality in the future. The
prevalence of HCV infection is estimated to be 2%, representing 123 million people
in the world. [Shepard et al., 2005]
HCV is characterized by a high degree of genetic heterogeneity like human
immunodeficiency virus (HIV). [Zein, 2000] Although it is well known that
recombinant forms of HIV-1 have been prevalent in the world, [Peeters, 2001]
there have been few reports on recombination of HCV between different
genotypes/subtypes, suggesting that these events are rare in vivo and that the
HCV recombinant form is usually not viable. [Simmonds et al., 1994; Viazov et al.,
2000] However, there was a report on the genotype discrepancy between Core and
NS5B regions although the recombination crossover point was not clear.  [Yun et
al., 1996] Besides, the evidences of super-infection have been demonstrated
among human population [Herring et al., 2004; Kao et al., 1996] and experimental
animals, [Okamoto et al., 1994] suggesting the possible occurrence of
recombination. In fact, the natural inter- and intra-genotypic recombinants of
HCV (RF1_2k/1b and RF2_1a/1b) were recently found and the crossover points
were clearly indicated in NS2 and NS5B regions, respectively. [Colina et al., 2004;
Kalinina et al., 2002] The HCV recombination has been reported only in these
cases to date. [Simmonds et al., 2005]
Several studies reported that the positive rate for anti-HCV was 2.2% among
blood donors (Metro Davao, 1990) [Arguillas et al., 1991], and 4.6% among
inmates (Metro Manila) [Katayama et al., 1996] in the Philippines. Recently, it was
4shown in our study (Metro Cebu, 2002) that the HCV prevalence was extremely
high among injecting drug users (70%), especially among those except the trainees
in the rehabilitation centers (100%), as compared to other populations, such as sex
workers, antenatal clinic attendees, students and health care workers (0-2%)
[Agdamag et al., 2005] Most common HCV genotypes were 1a (55%) followed by
1b (27%), 2a (6%), 2b (3%) in Metro Manila (n=33) [Katayama et al., 1996] and
were 1a (65%) followed by 2b (35%) in Metro Cebu (n=23) [Agdamag et al., 2005].
In this study, a natural inter-genotypic recombinant was identified through




HCV genotyping has been conducted at the National Reference Laboratory-
STD AIDS Cooperative Central laboratory, San Lazaro Hospital (Metro Manila,
Philippines). Samples and/or patients were referred to this laboratory for
serologic, viral load testing and for genotyping in some limited cases. The
researchers explained the objectives and the procedures of the study by the local
language, and confirmed the patient’s intent to join the study by his/her signing
an informed consent form for the referred patients. The test was done
anonymously under unlinked procedure for the referred samples.
Only seven samples from Metro Manila were available for the genotype test on
NS5B and 5’-UTR-Core regions, and the possible recombination was analyzed on
these samples. Risk factors and the travel history were not documented in the
sample profile sheet. Nucleotide sequences of the strains found at Metro Cebu
were from the database of STD AIDS Cooperative Central laboratory. [Agdamag et
al., 2005]
RNA extraction, cDNA synthesis and amplification
HCV-RNA was extracted from 100µl of plasma using SMITEST EX-R&D (Genome
Science Laboratories, Fukushima, Japan), and reverse-transcribed with random
primers according to First-Strand cDNA Synthesis protocol (Invitrogen, Carlsbad,
CA, USA).
cDNAs were amplified by nested PCR with the primers hep31b/hep32 and
hep33b/hep34b in the first and second rounds, respectively, for the phylogenetic
6analysis of NS5B as reported before. [White et al., 2000] The nested PCR for the
region of 5’-UTR-Core was done with the primers of KY80/C0751R (5’-
ATGTACCCCATGAGGTCGGC-3’) and hep21b/C0727R (5’-
CCACACGTAATGGTATCGATGAC-3’). [White et al., 2000] These amplifications
were performed with 20µl reaction mixture containing 2.5mM MgCl2, 200µM each
dNTP, 0.5µM primers and one unit of Amplitaq Gold® (Applied Biosystems, Foster
City, CA, USA). The thermal profile of the first-round PCR included one cycle of
94ºC for 10 min; 40 cycles of 94ºC for 30 sec, 55ºC for NS5B and 50ºC for 5’-UTR-
Core for 30 sec, and 72ºC for 1min per kb; and a final extension of 72ºC for 10 min,
respectively. The profile of the second-round PCR was done in the same condition
except for the annealing temperature at 60ºC for NS5B and 50ºC for 5’-UTR-Core,
respectively. PCR amplification was confirmed by visualization with ethidium
bromide staining of the gel.
Similarly, a putative recombinant HCV-RNA was reverse-transcribed with
random primer (Invitrogen) and the cDNAs were amplified with several gene
specific primers for the 11 regions (Fig. 1).
Determination of nucleotide sequences
A PCR product was subjected to the determination of nucleotide sequence
directly with the primers of hep33b/hep34b for NS5B, and hep21b/C0727R for
5’-UTR-Core, respectively, for the phylogenetic analysis of NS5B and 5’-UTR-Core
regions. The sequences were aligned with those retrieved from the HCV sequences
database (GenBank/EMBL/DDBJ) through ClustalW after the subsequent
inspection and manual modification. [Thompson et al., 1994] The frequency of
7nucleotide substitution in each base of the sequences was estimated by the Kimura
two-parameter method. A phylogenetic tree was constructed by the neighbor-
joining method, and its reliability was estimated by 1000 bootstrap replications.
The profile of the tree was visualized with the program of Njplot. [Perriere and
Gouy, 1996]
Several PCR-products were cloned into pCR2.1®-TOPO® vector in TOPO TA
Cloning® kit (Invitrogen) and the nucleotide sequences were determined with the
M13 primers in the kit (Invitrogen), the primers used for PCR, and newly
synthesized ones to determine the sequence of a possible recombinant HCV strain
(Fig.1). Three plasmids were subjected to the nucleotide sequence determination
per each fragment of total 11 parts (Fig.1), and the representative sequence was
considered to be one of the 11 tandem parts of the recombinant HCV sequence
(9315 bp; 3014 amino acids including the entire open reading frame). The
reliability of the determined nucleotide sequences was assessed by the ‘Quality
Value’ in ABI PRIZM® Sequence Analysis Software (Applied Biosystems).
Recombination analysis
The sequence of the recombinant candidate, SE-03-07-1689, was aligned with
reference sequences obtained from HCV sequence database, M62321_1a,
AB049087_1b, AB191333_1b, AF169004_2a, AY232747_2b, and AF238486_2b
(named after the accession numbers and subtypes), through ClustalW after the
subsequent inspection and manual modification. [Thompson et al., 1994]  The
Single-Sequence Viewer of Recombination Analysis Tool (RAT) was used to
examine recombination crossover point according to the user’s guide available in
8the RAT home page (http://cbr.jic.ac.uk/dicks/software/RAT/index.html).
[Etherington et al., 2005]
Nucleotide sequence accession number
The sequences reported herein have been deposited in GenBank/EMBL/DDBJ
under accession numbers of DQ364460 for SE-03-07-1689, DQ648505 to
DQ648517 for 13 NS5B sequences (Fig. 2A), and DQ648495 to DQ648504 for ten
5’-UTR-Core sequences (Fig. 2B).
9RESULTS
Phylogenetic analysis of the NS5B and 5’-UTR-Core regions
The NS5B and 5’-UTR-Core regions of seven strains collected in Metro Manila
were analyzed (Fig. 2). Those seven strains were classified into subtype-1b (n=4)
and 2a (n=3) based on NS5B (Fig. 2A), and subtype-1b (n=3), 2a (n=3) and 2b
(n=1) on 5’-UTR-Core (Fig. 2B). One strain (SE-03-07-1689) belonged to the
discordant subtypes, 2b (5’-UTR-Core, Fig. 2B) and 1b (NS5B, Fig. 2A).
Identification of the recombination crossover point
The sequence of SE-03-07-1689 from 5’-UTR-Core to the 5’ part of NS3 was
similar to that of the subtype 2b reference strains (Fig. 3). However, the 3’ part
sequence of this region was no more belonging to subtype 2b and was rather
similar to the sequence of subtype 1b. The computation of similarity was
performed to identify the recombination crossover point with RAT application
based on the 9.4kb-sequence (1-9394, start-end; 939, window size; 469, increment
size), and gave a crossover point within NS3 region. The shorter sequences within
the single insert, #6(S4) (Fig.1), were compared with the corresponding ones of
reference strains through RAT to analyze more accurate crossover point. The
window size and the target sequence length in this analysis were decreased from
939 to 40 and from 9394 to 400, respectively. The crossover point was then
located in the position of 3399/3400, corresponding to 3466/3467 of pj6CF strain
[Yanagi et al., 1999] (Fig. 3, inset; and Fig. 4).
10
DISCUSSION
An HCV strain (SE-03-07-1689) belonged to the discordant subtypes, 2b and
1b, based on the sequences of 5’-UTR-Core and NS5B regions, respectively. The
subsequent analysis of the genome sequence coding for the entire open reading
frame identified the recombination crossover point within NS3 region and
demonstrated the existence of natural inter-genotypic HCV recombinant strain
(2b/1b, SE-03-07-1689) in the Philippine population. The parental strains of SE-
03-07-1689 might exist in the Philippines because the phylogenetic analyses (Fig.
2) suggested that some HCV strains in the Philippines belonged to the same cluster
with SE-03-07-1689. However, it is dispensable to perform more intensive
investigation on the prevalence of recombinant HCV in Metro Manila and other
areas of the Philippines.
The identification of the recombinant crossover point provided the final proof
of the existence of a natural recombinant strain. [Kalinina et al., 2002] The
recombinant crossover point was located in the NS3 region of the SE-03-07-1689
strain through RAT analysis, and was apparently mapped at 3399/3400
corresponding to 3466/3467 of pj6CF strain [Yanagi et al., 1999] between Glycine
and Leucine residues in this study. However, only one strain (SE-03-07-1689) was
used for the determination of recombination crossover point. The flanking
sequences of the point derived from other recombinants and possible parental
strains circulating in Metro Manila are needed to identify a more accurate
crossover point of SE-03-07-1689 strain.
The recombination point had been often found in the genome coding the first
non-structural protein, e.g., NS2 of HCV recombinants [Kalinina et al., 2002] and
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NS1 of Dengue viruses, also members of Flaviviriae. [Tolou et al., 2001] However,
analysis of the crossover junction of the SE-03-07-1689 was in the NS3 next to NS2
and this is discordant with the previous findings. Recombination crossover point
was NS5B in the intra-genotype recombination case found in Peru, not in the
genome coding the first non-structural protein. [Colina et al., 2004] Further
demonstrations and comparisons must be required to elucidate the regularity
principle of an HCV recombination. It is expected that analysis of the
recombination crossover points would be accelerated through the recently
developed cell culture system. [Heller et al., 2005; Lindenbach et al., 2005; Wakita
et al., 2005; Zhong et al., 2005]
The genotype of HCV influences on the outcome of interferon treatment [Zein,
2000] and the interferon sensitivity has been attributed to the sequence
variability of NS5A and E2. [Gale et al., 1998; Gale et al., 1997; Pavio et al., 2002;
Polyak et al., 2001; Taylor et al., 2005; Taylor et al., 1999] The recombination
events at NS2 in St Petersburg [Kalinina et al., 2002] and NS3 in Metro Manila
implies that the genotype determination through the analysis of one subgenomic
region, such as NS5B, may not be enough to assess the anti-HCV activity of
interferon. It might be necessary to analyze the responsible nucleotide sequences
in E2 and NS5A regions themselves for the assessment of antiviral activity. This
assessment procedure beyond the simple genotyping would become indispensable
when the frequency of HCV recombination proves to be a common event.
HCV strains are divided into genotypes, subtypes, and quasispecies, in the
current HCV classification system and the recent consensus proposals. [Simmonds
et al., 2005; Zein, 2000] However, recombination has not been considered in this
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classification. Therefore, this recombinant strain found in the Metro Manila of the
Philippines, SE-03-07-1689, is tentatively designated as RF3_2b/1b according to
the suggestions used for other two strains (RF1_2k/1b and RF2_1a/1b) already
reported as the HCV recombinants. [Colina et al., 2004; Kalinina et al., 2002] The
existence of an HCV recombinant in the Philippines in addition to recent findings
in St Petersburg and Lima implies that HCV recombination may have an important
implication for the pathogenesis, diagnosis and treatment in HCV infection.
Further prevalence study of HCV recombinants might have an important role for
the discussion on the clinical impact of the HCV recombination event.
13
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Fig. 1 Strategy for the sequence determination of an HCV strain, SE-03-
07-1689. A genetic organization of HCV is indicated with blocks (coding regions)
and a flanking bar (5’-untranslated region, 5’-UTR). The numbers on the block
denote the starting positions of the coding regions except the last one (the last
nucleotide position), where the position (+1) corresponds to the 5’-end of Core
region. The bar under the block defines the complementary DNA that was
subjected to polymerase chain reaction (PCR), cloning into a vector, and a
sequence determination. A primer ID was named after the 5’-end position of the
nucleotide sequences of the reference strains (accession numbers; D10988
(genotype-2b) and D90208 (genotype-1b) (italic)) used for the primer design. The
forward and reverse directions are indicated with F and R, respectively. Primers
used for the sequence determination are shown in the parentheses.
Fig. 2 Phylogenetic analysis of the HCV strains on 222 and 538 nucleotides
within the NS5B (A) and 5’-UTR-Core (B) regions. The tree was constructed by the
neighbor-joining method using ClustalW program with GBV-B (accession number;
NC001655) as the outgroup. Strains including the SE-03-07-1689 (boxed) are
indicated with two digits of the collecting year and the location, such as MM Phil
and MC Phil, denoting the Metro Manila and Metro Cebu, Philippines (e.g.,
03_CD_MM_Phil and 02_CCDQ4_MC_Phil). Accession numbers are used for the
reference strains with two digits indicating genotypes at the end of the number.
Bootstrap values (>70%) are given on blanches as percentages from 1,000
replicates.
Fig. 3 Similarity plots for a putative recombinant strain, SE-03-07-1689, and
reference strains based on the 9.4kb-sequences and a #6(S4) fragment (inset). The
plot was performed with the Recombination Analysis Tool (RAT). Four reference
sequences of HCV genotype-1b  (AB049087 and AB191333) and -2b (AY232747
and AF238486) with the highest sequence scores (through the BLAST program) on
the similarity to the sequence of SE-03-07-1689 were selected from
GenBank/EMBL/DDBJ sequence database. Two sequences of M62321 (genotype-
1a) and AF169004 (2a) were also selected from ‘Ready made alignments’ of the Los
Alamos HCV sequences database. The recombination analysis was performed
throughout 9384 bases with a window size of 938 and a step increment of 469, and
also 400 bases in the #6(S4) fragment with a window size of 40 and an increment
of 20 (inset), respectively. An arrow indicates the crossover point between the
nucleotide positions of 3399 and 3400 (inset).
Fig. 4 Alignment of the nucleotide sequences of SE-03-07-1689 and four
reference sequences; AF238486, AY232747, AB049087 and AB191333 within
#6(S4) fragment. Arrow indicates the possible crossover point (3399/3400). The
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